Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldBoltz
Categories
healthcaredrug-discoveryai-infrastructure
HQCambridge, USA
Founded2024
Latest valuation—
Annual Recurring Revenue (ARR)—
Funding to date$25M+
Headcount—
Profitability—
Statusactive
Pricing tierenterprise
DescriptionPublic benefit corporation developing commercially-available co-folding AI models (Boltz-1) achieving AlphaFold 3-level accuracy in predicting 3D structures of biomolecular complexes. Enables structure-guided drug discovery by predicting protein-protein interactions, small-molecule binding, and biologics design.